Jeff Yass’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-64,900
| Closed | -$201K | – | 14670 |
|
|
2021
Q4 | $201K | Buy |
64,900
+29,200
| +82% | +$98.3K | ﹤0.01% | 11446 |
|
|
2021
Q3 | $129K | Buy |
35,700
+14,500
| +68% | +$54.7K | ﹤0.01% | 11904 |
|
|
2021
Q2 | $76K | Buy |
21,200
+1,200
| +6% | +$4.23K | ﹤0.01% | 12197 |
|
|
2021
Q1 | $78K | Buy |
+20,000
| New | +$82.6K | ﹤0.01% | 11942 |
|
|
2020
Q4 | – | Sell |
-96,500
| Closed | -$360K | – | 12180 |
|
|
2020
Q3 | $360K | Buy |
96,500
+67,300
| +230% | +$286K | ﹤0.01% | 8343 |
|
|
2020
Q2 | $127K | Sell |
29,200
-39,100
| -57% | -$176K | ﹤0.01% | 9373 |
|
|
2020
Q1 | $259K | Buy |
68,300
+4,800
| +8% | +$23.6K | ﹤0.01% | 8255 |
|
|
2019
Q4 | $401K | Buy |
63,500
+43,600
| +219% | +$256K | ﹤0.01% | 7420 |
|
|
2019
Q3 | $84K | Sell |
19,900
-300
| -1% | -$1.28K | ﹤0.01% | 9639 |
|
|
2019
Q2 | $94K | Sell |
20,200
-48,400
| -71% | -$225K | ﹤0.01% | 9633 |
|
|
2019
Q1 | $364K | Buy |
68,600
+55,600
| +428% | +$254K | ﹤0.01% | 6874 |
|
|
2018
Q4 | $48K | Buy |
+13,000
| New | +$45.7K | ﹤0.01% | 8506 |
|
|
2018
Q3 | – | Sell |
-20,500
| Closed | -$60K | – | 10955 |
|
|
2018
Q2 | $60K | Buy |
20,500
+1,300
| +7% | +$3.08K | ﹤0.01% | 9225 |
|
|
2018
Q1 | $43K | Sell |
19,200
-30,300
| -61% | -$70.9K | ﹤0.01% | 9003 |
|
|
2017
Q4 | $146K | Sell |
49,500
-40,600
| -45% | -$112K | ﹤0.01% | 8508 |
|
|
2017
Q3 | $266K | Sell |
90,100
-3,200
| -3% | -$9.75K | ﹤0.01% | 7591 |
|
|
2017
Q2 | $261K | Buy |
93,300
+13,000
| +16% | +$27.4K | ﹤0.01% | 7829 |
|
|
2017
Q1 | $153K | Sell |
80,300
-1,200
| -1% | -$2.31K | ﹤0.01% | 8185 |
|
|
2016
Q4 | $143K | Buy |
81,500
+19,200
| +31% | +$39.2K | ﹤0.01% | 8883 |
|
|
2016
Q3 | $168K | Sell |
62,300
-30,500
| -33% | -$77.5K | ﹤0.01% | 7709 |
|
|
2016
Q2 | $219K | Sell |
92,800
-278,900
| -75% | -$770K | ﹤0.01% | 7461 |
|
|
2016
Q1 | $1.2M | Sell |
371,700
-133,600
| -26% | -$494K | ﹤0.01% | 4728 |
|
|
2015
Q4 | $2.42M | Sell |
505,300
-85,800
| -15% | -$486K | ﹤0.01% | 3667 |
|
|
2015
Q3 | $3.29M | Sell |
591,100
-38,900
| -6% | -$287K | ﹤0.01% | 3335 |
|
|
2015
Q2 | $5.01M | Buy |
630,000
+290,500
| +86% | +$2.5M | ﹤0.01% | 2905 |
|
|
2015
Q1 | $3.56M | Buy |
339,500
+321,500
| +1,786% | +$4.39M | ﹤0.01% | 3247 |
|
|
2014
Q4 | $216K | Sell |
18,000
-13,900
| -44% | -$211K | ﹤0.01% | 8682 |
|
|
2014
Q3 | $545K | Sell |
31,900
-99,600
| -76% | -$1.45M | ﹤0.01% | 7039 |
|
|
2014
Q2 | $1.59M | Buy |
+131,500
| New | +$1.25M | ﹤0.01% | 5102 |
|
Other funds holding BDSI
Jeff Yass's BDSI Position: Q1 2022 in Review
Jeff Yass sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 323,783 shares — an estimated $1M sold.
Jeff Yass first reported a position in BDSI in Q3 2013 and held it in 32 quarters. The position peaked at $4.57M in Q3 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Jeff Yass reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Jeff Yass sold 323,783 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1M.
- Jeff Yass first reported a position in BioDelivery Sciences International, Inc. in Q3 2013 and held it in 32 quarters.
- Jeff Yass's BioDelivery Sciences International, Inc. position peaked at $4.57M in Q3 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.